Obese PCOS patients and hyperinsulinemic PCOS patients demonstrate an exaggerated insulinotropic effect of glucagon, with significantly higher insulin levels following glucagon infusion compared to lean PCOS patients and normo-ovulatory controls (Ciampelli et al. 1998). The gene discussed is INS; the disease is polycystic ovary syndrome.